# LIPFENDRA
> **NDA220848** · New Drug Application · Sponsor: MSD · Approved 2026-07-15
## Drug
- **FDA Application Number:** NDA220848
- **Application type:** New Drug Application
- **Brand name:** LIPFENDRA
- **Generic name:** LIPFENDRA
- **Active ingredients:** ENLICITIDE DECANOATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2026-07-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220848)
---
*MORVS · CC0 1.0*